Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.14%
0%
-17.14%
6 Months
-17.14%
0%
-17.14%
1 Year
5.45%
0%
5.45%
2 Years
-35.56%
0%
-35.56%
3 Years
-64.85%
0%
-64.85%
4 Years
-75.83%
0%
-75.83%
5 Years
-62.58%
0%
-62.58%
Surgical Innovations Group Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.72%
EBIT Growth (5y)
13.25%
EBIT to Interest (avg)
-0.67
Debt to EBITDA (avg)
0.10
Net Debt to Equity (avg)
0.06
Sales to Capital Employed (avg)
0.93
Tax Ratio
5.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.14%
ROE (avg)
0.54%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.63
EV to EBIT
-6.34
EV to EBITDA
6.34
EV to Capital Employed
0.67
EV to Sales
0.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.73%
ROE (Latest)
-4.98%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
Bullish
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
12.00
11.30
6.19%
Operating Profit (PBDIT) excl Other Income
0.20
0.70
-71.43%
Interest
0.10
0.10
Exceptional Items
0.00
-0.00
Consolidate Net Profit
-0.50
0.30
-266.67%
Operating Profit Margin (Excl OI)
-49.60%
13.70%
-6.33%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 6.19% vs 24.18% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -266.67% vs 160.00% in Dec 2022
About Surgical Innovations Group Plc 
Surgical Innovations Group Plc
Pharmaceuticals & Biotechnology
Surgical Innovations Group plc is a United Kingdom-based holding company, which is involved in the design, development, manufacture and sale of devices for use in minimally invasive surgery (SI) and precision engineering (PE) markets. The Company sells branded products through independent healthcare distributors across the world and own label products through original equipment manufacturer (OEM) relationships. The Company operates through three segments: SI Brand, OEM and PE. The SI Brand segment is engaged in the research, development, manufacture and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The PE segment is engaged in the research, development, manufacture and sale of minimally invasive technology products for PE applications.
Company Coordinates 
Company Details
Clayton Wood House, 6 Clayton Wood Bank , LEEDS None : LS16 6QZ
Registrar Details






